These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14724874)

  • 1. Unexpected cardiovascular deaths are rare with therapeutic doses of droperidol.
    Mullins M; Van Zwieten K; Blunt JR
    Am J Emerg Med; 2004 Jan; 22(1):27-8. PubMed ID: 14724874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Droperidol: should the black box be light gray?
    Dershwitz M
    J Clin Anesth; 2002 Dec; 14(8):598-603. PubMed ID: 12565120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?
    Nuttall GA; Eckerman KM; Jacob KA; Pawlaski EM; Wigersma SK; Marienau ME; Oliver WC; Narr BJ; Ackerman MJ
    Anesthesiology; 2007 Oct; 107(4):531-6. PubMed ID: 17893447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA "black box" warning regarding use of droperidol for postoperative nausea and vomiting: is it justified?
    Gan TJ; White PF; Scuderi PE; Watcha MF; Kovac A
    Anesthesiology; 2002 Jul; 97(1):287. PubMed ID: 12131145
    [No Abstract]   [Full Text] [Related]  

  • 5. Droperidol in the emergency department: is it safe?
    Richards JR; Schneir AB
    J Emerg Med; 2003 May; 24(4):441-7. PubMed ID: 12745049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Droperidol, QT prolongation, and sudden death: what is the evidence?
    Kao LW; Kirk MA; Evers SJ; Rosenfeld SH
    Ann Emerg Med; 2003 Apr; 41(4):546-58. PubMed ID: 12658255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Droperidol: many questions, few answers.
    Scuderi PE
    Anesthesiology; 2003 Feb; 98(2):289-90. PubMed ID: 12552182
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA response to droperidol black box warning editorials.
    Rappaport BA
    Anesth Analg; 2008 May; 106(5):1585. PubMed ID: 18420886
    [No Abstract]   [Full Text] [Related]  

  • 9. Pro: The Food and Drug Administration Black box warning on droperidol is not justified.
    Habib AS; Gan TJ
    Anesth Analg; 2008 May; 106(5):1414-7. PubMed ID: 18420854
    [No Abstract]   [Full Text] [Related]  

  • 10. Droperidol editorial: making a mountain out of a mole hill!
    Bailey P; White PF
    Anesthesiology; 2003 Sep; 99(3):760-1; author reply 761. PubMed ID: 12960572
    [No Abstract]   [Full Text] [Related]  

  • 11. Con: The black box warning on droperidol should not be removed (but should be clarified!).
    Ludwin DB; Shafer SL
    Anesth Analg; 2008 May; 106(5):1418-20. PubMed ID: 18420855
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-dose droperidol.
    Allen G
    CMAJ; 2002 Sep; 167(5):452; author reply 452. PubMed ID: 12240805
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of droperidol before and after the Food and Drug Administration black box warning: a survey of the members of the Society of Ambulatory Anesthesia.
    Habib AS; Gan TJ
    J Clin Anesth; 2008 Feb; 20(1):35-9. PubMed ID: 18346607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does low-dose droperidol increase the risk of polymorphic ventricular tachycardia or death in the surgical patient?
    Nuttall GA; Malone AM; Michels CA; Trudell LC; Renk TD; Marienau ME; Oliver WC; Ackerman MJ
    Anesthesiology; 2013 Feb; 118(2):382-6. PubMed ID: 23291623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based review of the black-box warning for droperidol.
    Jackson CW; Sheehan AH; Reddan JG
    Am J Health Syst Pharm; 2007 Jun; 64(11):1174-86. PubMed ID: 17519460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Droperidol and the black box warning.
    van Zwieten K; Mullins ME; Jang T
    Ann Emerg Med; 2004 Jan; 43(1):139-40. PubMed ID: 15259182
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-dose droperidol (≤1 mg or ≤15 μg kg-1) for the prevention of postoperative nausea and vomiting in adults: quantitative systematic review of randomised controlled trials.
    Schaub I; Lysakowski C; Elia N; Tramèr MR
    Eur J Anaesthesiol; 2012 Jun; 29(6):286-94. PubMed ID: 22488335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the safety of 5-HT3 antagonists with dexamethasone or droperidol for prevention of PONV.
    Leslie JB; Gan TJ
    Ann Pharmacother; 2006 May; 40(5):856-72. PubMed ID: 16670360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol: an alternative butyrophenone for nausea and vomiting prophylaxis in anesthesia.
    Smith JC; Wright EL
    AANA J; 2005 Aug; 73(4):273-5. PubMed ID: 16108408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol for postoperative nausea and vomiting: are we reinventing the wheel?
    Habib AS; Gan TJ
    Anesth Analg; 2008 May; 106(5):1343-5. PubMed ID: 18420842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.